ALIOF Recent News UCB Misses Earnings Ests, Revs
Post# of 5
UCB Misses Earnings Ests, Revs In Line - Analyst Blog Zacks Investment Research - Thu Feb 27, 12:32PM CST
Shares Fall as Aegerion Posts Wider-than-Expected Loss - Analyst Blog Zacks Investment Research - Thu Feb 27, 12:26PM CST
Actelion's novel antibiotic cadazolid receives US FDA Qualified Infectious Disease Product designation for the treatment of Clostridium difficile-associated diarrhea Thomson Reuters ONE - Thu Feb 27, 10:35AM CST
Encouraging News from Pfizer - Analyst Blog Zacks Investment Research - Tue Feb 25, 4:25PM CST
NewLink Genetics (NLNK) Jumps: Stock Moves 8.2% Higher - Tale of the Tape Zacks Investment Research - Tue Feb 25, 8:46AM CST
Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% - Tale of the Tape Zacks Investment Research - Tue Feb 25, 8:25AM CST
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog Zacks Investment Research - Mon Feb 24, 4:20PM CST
Vertex' Kalydeco Approved for an Additional Indication - Analyst Blog Zacks Investment Research - Mon Feb 24, 12:00PM CST
Encouraging Data on Bristol-Myers/Pfizer's Eliquis - Analyst Blog Zacks Investment Research - Mon Feb 24, 10:50AM CST
Retrophin (RTRX) Jumps: Stock Moves 14.3% Higher - Tale of the Tape Zacks Investment Research - Mon Feb 24, 8:46AM CST